6
Oct
2026

Nabiqasim Industries (Pvt.) Ltd.

Exhibitor at CPHI Milan 2026 stand 16A55, Finished Dosage & Formulation
About Us

A leading pharmaceutical manufacturing company of Pakistan, delivering high quality Finished Pharmaceutical Formulations (Lyophilization, Prostaglandins, Creams, Ointments, Enemas, Tablets, Capsules, Syrups & Infusions) to the local market and across the globe. Please visit us at Stall No. 9.1A69 at CPHI FRANKFURT 2025

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Pakistan
  • On CPHI since:
    2023
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • +9221 111 742 762
  • 5th Floor, Commerce Centre,, Hasrat Mohani Road, 74200, Karachi, Pakistan
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 16A55, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Cardiovascular

    Product Cardiovascular

    Nabiqasim offers a wide range of Cardiovascular products in combination and single ingredient including APIXABAN; RIVIROXABAN; SACUBITRIL+VALSARTAN; ROSUVASTATIN+EZETIMIBE and many others. 
  • Hypoglycemics

    Product Hypoglycemics

    Nabiqasim offers a wide range of Hypoglycemic products including DAPAGLIFLOZIN+METFORMIN HYDROCHLORIDE EXTENDED RELEASE; EMPAGLIFLOZIN + METFORMIN HYDROCHLORIDE;  EMPAGLIFLOZIN+LINAGLIPTIN+METFORMIN HYDROCHLORIDE EXTENDED RELEASE and many others
  • Lyophilization (ANVISA APPROVED) / Hormonal Section /Dydrogesterone (PIC/S APPROVED)

    Product Lyophilization (ANVISA APPROVED) / Hormonal Section /Dydrogesterone (PIC/S APPROVED)

    Lyophilized vials